Joanna Fay

1.7k total citations
41 papers, 1.0k citations indexed

About

Joanna Fay is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Joanna Fay has authored 41 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 19 papers in Oncology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Joanna Fay's work include HER2/EGFR in Cancer Research (9 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Cell death mechanisms and regulation (5 papers). Joanna Fay is often cited by papers focused on HER2/EGFR in Cancer Research (9 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Cell death mechanisms and regulation (5 papers). Joanna Fay collaborates with scholars based in Ireland, Sweden and United States. Joanna Fay's co-authors include Stefan Schwartz, H. Lambkin, Kenneth Bryan, Maria Meehan, Elaine W. Kay, Daniel Öberg, Jochen H.M. Prehn, Orna Bacon, Deborah A. McNamara and Xiaomin Zhao and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The EMBO Journal.

In The Last Decade

Joanna Fay

36 papers receiving 984 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joanna Fay Ireland 16 643 254 241 187 156 41 1.0k
Rolf Schwarzer Germany 14 617 1.0× 145 0.6× 142 0.6× 169 0.9× 174 1.1× 28 1.3k
Kezhen Li China 22 636 1.0× 228 0.9× 162 0.7× 336 1.8× 266 1.7× 61 1.5k
Gangqiang Guo China 18 634 1.0× 427 1.7× 142 0.6× 197 1.1× 218 1.4× 49 1.1k
Gabriel N. Maine United States 18 561 0.9× 297 1.2× 95 0.4× 302 1.6× 385 2.5× 28 1.3k
Randie H. Kim United States 16 357 0.6× 227 0.9× 242 1.0× 241 1.3× 79 0.5× 75 1.3k
Patricia Tsang United States 20 336 0.5× 145 0.6× 168 0.7× 304 1.6× 102 0.7× 30 1.1k
Tetsuhiko Asao Japan 18 309 0.5× 160 0.6× 88 0.4× 369 2.0× 124 0.8× 66 932
Faris Farassati United States 17 401 0.6× 105 0.4× 157 0.7× 402 2.1× 85 0.5× 44 942

Countries citing papers authored by Joanna Fay

Since Specialization
Citations

This map shows the geographic impact of Joanna Fay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanna Fay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanna Fay more than expected).

Fields of papers citing papers by Joanna Fay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanna Fay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanna Fay. The network helps show where Joanna Fay may publish in the future.

Co-authorship network of co-authors of Joanna Fay

This figure shows the co-authorship network connecting the top 25 collaborators of Joanna Fay. A scholar is included among the top collaborators of Joanna Fay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanna Fay. Joanna Fay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fay, Joanna, Lance Hudson, Adrian Murphy, et al.. (2024). Synergistic Effects of the Combination of Alpelisib (PI3K Inhibitor) and Ribociclib (CDK4/6 Inhibitor) in Preclinical Colorectal Cancer Models. International Journal of Molecular Sciences. 25(24). 13264–13264. 9 indexed citations
2.
Tosetto, Miriam, Joanna Fay, Elaine W. Kay, et al.. (2024). Caspase-4 Has Potential Utility as a Colorectal Tissue Biomarker for Dysplasia and Early-Stage Cancer. SHILAP Revista de lepidopterología. 4(2). 100552–100552.
3.
Duggan, William P., Ina Woods, Heiko Düßmann, et al.. (2024). Spatial transcriptomic analysis reveals local effects of intratumoral fusobacterial infection on DNA damage and immune signaling in rectal cancer. Gut Microbes. 16(1). 2350149–2350149. 5 indexed citations
4.
Duggan, William P., Manuela Salvucci, Andreas U. Lindner, et al.. (2023). Increased Fusobacterium tumoural abundance affects immunogenicity in mucinous colorectal cancer and may be associated with improved clinical outcome. Journal of Molecular Medicine. 101(7). 829–841. 6 indexed citations
5.
Gonzalez, Claudia Aura, Anthony O’Grady, Joanna Fay, et al.. (2023). The immune microenvironment in hormone positive, HER2 negative breast cancer: A focus on tumour infiltrating lymphocytes, spatial phenotypes and tertiary lymphoid structures.. Journal of Clinical Oncology. 41(16_suppl). 2522–2522. 1 indexed citations
6.
Elamin, Yasir Y., Kathy Gately, Shereen Rafee, et al.. (2023). Protein Tyrosine Phosphatase Non-Receptor 11 (PTPN11/Shp2) as a Driver Oncogene and a Novel Therapeutic Target in Non-Small Cell Lung Cancer (NSCLC). International Journal of Molecular Sciences. 24(13). 10545–10545. 7 indexed citations
7.
Krzyzanowska, Agnieszka, Stephen Barron, Debra F. Higgins, et al.. (2023). Development, Validation, and Clinical Utility of a Six-gene Signature to Predict Aggressive Prostate Cancer. European Urology Focus. 9(6). 983–991. 1 indexed citations
8.
Gonzalez, Claudia Aura, Joanna Fay, Anthony O’Grady, et al.. (2022). CD45-positive tumor infiltrating lymphocytes in early-stage hormone-positive, HER2-negative (ER+/HER2-) breast cancer: Correlation with proliferation and prognostic signature scores.. Journal of Clinical Oncology. 40(16_suppl). e12555–e12555. 1 indexed citations
9.
Toomey, Sinéad, Robert Smyth, Stephen F. Madden, et al.. (2022). Exhaled Breath Condensate (EBC) analysis of circulating tumour DNA (ctDNA) using a lung cancer specific UltraSEEK oncogene panel. Lung Cancer. 168. 67–73. 12 indexed citations
10.
11.
Sheehan, Katherine M., Elaine W. Kay, Charlotta Hedner, et al.. (2021). Development of a Novel Weighted Ranking Method for Immunohistochemical Quantification of a Heterogeneously Expressed Protein in Gastro-Esophageal Cancers. Cancers. 13(6). 1286–1286.
12.
Hudson, Lance, Joanna Fay, Hanne Jahns, et al.. (2021). Transcriptional CDK inhibitors, CYC065 and THZ1 promote Bim-dependent apoptosis in primary and recurrent GBM through cell cycle arrest and Mcl-1 downregulation. Cell Death and Disease. 12(8). 763–763. 10 indexed citations
13.
14.
Toomey, Sinéad, Stephen F. Madden, Simon J. Furney, et al.. (2016). The impact of ERBB-family germline single nucleotide polymorphisms on survival response to adjuvant trastuzumab treatment in HER2-positive breast cancer. Oncotarget. 7(46). 75518–75525. 10 indexed citations
15.
Eustace, Alex J., Sinéad Toomey, Joanna Fay, et al.. (2016). The clinical impact of early immunological responses in human HER2-positive breast cancers on responsiveness to trastuzumab-based therapy.. Journal of Clinical Oncology. 34(15_suppl). 587–587. 1 indexed citations
16.
Flanagan, Lorna, Joanna Fay, Orna Bacon, et al.. (2015). High levels of X-linked Inhibitor-of-Apoptosis Protein (XIAP) are indicative of radio chemotherapy resistance in rectal cancer. Radiation Oncology. 10(1). 131–131. 42 indexed citations
17.
Flanagan, Lorna, Andreas U. Lindner, Joanna Fay, et al.. (2014). BCL2 protein signalling determines acute responses to neoadjuvant chemoradiotherapy in rectal cancer. Journal of Molecular Medicine. 93(3). 315–326. 12 indexed citations
18.
Johansson, Cecilia, Xiaoze Li, Joanna Fay, et al.. (2012). HPV‐16 E2 contributes to induction of HPV‐16 late gene expression by inhibiting early polyadenylation. The EMBO Journal. 31(14). 3212–3227. 63 indexed citations
19.
Rush, Margaret, Joanna Fay, Fergus Ryan, et al.. (2008). Adenovirus E4orf4 induces HPV-16 late L1 mRNA production. Virology. 383(2). 279–290. 13 indexed citations
20.
Zhao, Xiaomin, Joanna Fay, H. Lambkin, & Stefan Schwartz. (2007). Identification of a 17-nucleotide splicing enhancer in HPV-16 L1 that counteracts the effect of multiple hnRNP A1-binding splicing silencers. Virology. 369(2). 351–363. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rolf Schwarzer Breakdown of academic impact, for papers by Kezhen Li Breakdown of academic impact, for papers by Gangqiang Guo Breakdown of academic impact, for papers by Gabriel N. Maine Breakdown of academic impact, for papers by Randie H. Kim Breakdown of academic impact, for papers by Patricia Tsang Breakdown of academic impact, for papers by Tetsuhiko Asao Breakdown of academic impact, for papers by Faris Farassati
Rankless by CCL
2026